SSX7 Antikörper (Middle Region)

Produktnummer ABIN928570

Produktdetails anti-SSX7 Antikörper

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Bindungsspezifität: Middle Region

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SSX7 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: SSX7 antibody was raised in rabbit using the middle region of SSX7 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

SSX7 Blocking Peptide, catalog no. 33R-3959, is also available for use as a blocking control in assays to test for specificity of this SSX7 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu SSX7

Target: SSX7 (Synovial Sarcoma, X Breakpoint 7 (SSX7))

Andere Bezeichnung: SSX7 (SSX7 Produkte)

Synonyme: SSX family member 7 antikoerper, SSX7 antikoerper

Hintergrund: SSX7 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. Synonyms: Polyclonal SSX7 antibody, Anti-SSX7 antibody, synovial sarcoma, X breakpoint 7 antibody.